BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33385797)

  • 1. Levels of the cancer biomarker CA 19-9 are associated with thrombin generation in plasma from treatment-naïve pancreatic cancer patients.
    Mattila N; Hisada Y; Przybyla B; Posma J; Jouppila A; Haglund C; Seppänen H; Mackman N; Lassila R
    Thromb Res; 2021 Mar; 199():21-31. PubMed ID: 33385797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered whole blood thrombin generation and hyperresponsive platelets in patients with pancreatic cancer.
    Willems RAL; Konings J; Huskens D; Middelveld H; Pepels-Aarts N; Verbeet L; de Groot PG; Heemskerk JWM; Ten Cate H; de Vos-Geelen J; de Laat B; Roest M
    J Thromb Haemost; 2024 Apr; 22(4):1132-1144. PubMed ID: 38237861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PO-27 - Thrombin generation in pancreatic cancer and multiple myeloma with use of calibrated automated thrombography.
    Adesanya MA; Maraveyas A; Madden LA
    Thromb Res; 2016 Apr; 140 Suppl 1():S186. PubMed ID: 27161715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies.
    Joly B; Barbay V; Borg JY; Le Cam-Duchez V
    Thromb Res; 2013 Sep; 132(3):386-91. PubMed ID: 23962423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin.
    Gezelius E; Flou Kristensen A; Bendahl PO; Hisada Y; Risom Kristensen S; Ek L; Bergman B; Wallberg M; Falkmer U; Mackman N; Pedersen S; Belting M
    PLoS One; 2018; 13(11):e0207387. PubMed ID: 30412630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma.
    Mattila N; Seppänen H; Mustonen H; Przybyla B; Haglund C; Lassila R
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1267-1275. PubMed ID: 29865859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
    Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.
    Riva N; Vella K; Hickey K; Bertù L; Zammit D; Spiteri S; Kitchen S; Makris M; Ageno W; Gatt A
    J Clin Pathol; 2018 Nov; 71(11):1015-1022. PubMed ID: 30093507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early thrombin formation capacity in trauma patients and association with venous thromboembolism.
    Voils SA; Lemon SJ; Jordan J; Riley P; Frye R
    Thromb Res; 2016 Nov; 147():13-15. PubMed ID: 27664391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram.
    Machlus KR; Colby EA; Wu JR; Koch GG; Key NS; Wolberg AS
    Thromb Haemost; 2009 Nov; 102(5):936-44. PubMed ID: 19888532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive tissue factor activity assay determined by an optimized thrombin generation method.
    Kristensen SR; Nybo J
    PLoS One; 2023; 18(7):e0288918. PubMed ID: 37467256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Step Toward Balance: Thrombin Generation Improvement via Procoagulant Factor and Antithrombin Supplementation.
    Mitrophanov AY; Szlam F; Sniecinski RM; Levy JH; Reifman J
    Anesth Analg; 2016 Sep; 123(3):535-46. PubMed ID: 27541717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of corn trypsin inhibitor on the contribution of coagulation determinants to the Technoclone Thrombin Generation Assay (TGA) and the Calibrated Automated Thrombogram (CAT).
    Touw CE; de Jong Y; van Hylckama Vlieg A
    PLoS One; 2022; 17(2):e0263960. PubMed ID: 35213588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Two Thrombin Generation Methods, CAT and ST-Genesia, in Liver Transplant Patients.
    Roullet S; Labrouche S; Freyburger G
    Thromb Haemost; 2019 Jun; 119(6):899-905. PubMed ID: 31005063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent high factor VIII activity leading to increased thrombin generation - a prospective cohort study.
    Ryland JK; Lawrie AS; Mackie IJ; Machin SJ
    Thromb Res; 2012 Apr; 129(4):447-52. PubMed ID: 21849206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OC-06 - Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer?
    Faille D; Ajzenberg N; de Chaisemartin L; Granger V; Chollet-Martin S; de Raucourt E; Hammel P; Lévy P; Ruszniewski P; Rebours V
    Thromb Res; 2016 Apr; 140 Suppl 1():S170-1. PubMed ID: 27161678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters.
    van Veen JJ; Gatt A; Cooper PC; Kitchen S; Bowyer AE; Makris M
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):183-9. PubMed ID: 18388496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells.
    Rousseau A; Larsen AK; Van Dreden P; Sabbah M; Elalamy I; Gerotziafas GT
    Int J Oncol; 2017 Dec; 51(6):1747-1756. PubMed ID: 29075790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum fibrinogen as a diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma.
    Chung KH; Lee JC; Lee J; Cho IK; Kim J; Jang W; Yoo BC; Hwang JH
    Pancreatology; 2020 Oct; 20(7):1465-1471. PubMed ID: 32873483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.